Scinai Immunotherapeutics Ltd. Skyrocketed
Fri, Apr 24, 2026 at 07:24 PM
Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ) jumped higher at $0.74, a gain of 61.6%. On Fri, Apr 24, 2026, SCNI:NASDAQ touched a New 2-Week High of $0.74. The stock appeared on our News Catalysts scanner on Fri, Apr 24, 2026 at 10:27 AM in the 'PRIVATE PLACEMENT' category. From Fri, Apr 10, 2026, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Apr 24, 2026 at $1.05 with a volume of 199M+.
About Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ)
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine.
Top 10 Gainers:
- MaxLinear, Inc. (MXL:NASDAQ), 76.12%
- Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ), 61.62%
- Atomera Incorporated (ATOM:NASDAQ), 38.93%
- Elong Power Holding Limited (ELPW:NASDAQ), 35.58%
- Organon & Co. (OGN:NYSE), 30.93%
- Akanda Corp. (AKAN:NASDAQ), 30.52%
- AEye, Inc. (LIDR:NASDAQ), 29.59%
- POET Technologies Inc. (POET:NASDAQ), 28.84%
- Cheetah Net Supply Chain Service Inc. (CTNT:NASDAQ), 28.4%
- Direxion Daily AMD Bull 2X Shares (AMUU:NASDAQ), 27.97%